(Q37833133)

24 August 2017

1 reference

title

Chronic kidney disease growth factors in renal fibrosis (English)

1 reference

chronic renal insufficiency

24 August 2017

main subject

1 reference

Peter Boor

1

0 references

author name string

Jürgen Floege

series ordinal

2

1 reference

24 August 2017

publication date

1 July 2011

1 reference

Clinical and Experimental Pharmacology and Physiology

24 August 2017

published in

1 reference

24 August 2017

volume

38

1 reference

24 August 2017

issue

7

1 reference

24 August 2017

page(s)

441-450

1 reference

Renal fibrosis: novel insights into mechanisms and therapeutic targets.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Polyclonal immunoglobulin G ameliorates the course of progressive mesangioproliferative glomerulonephritis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

TGF-beta signaling in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

TGF-beta isoforms in renal fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Latent TGF-beta1 protects against crescentic glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

miR-192 mediates TGF-beta/Smad3-driven renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Circulating transforming growth factor-beta1 levels and the risk for kidney disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Association of advanced vasculopathy and transforming growth factor-beta1 gene expression with immunoglobulin A nephropathy progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

CTGF inhibits BMP-7 signaling in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Modulator of bone morphogenetic protein activity in the progression of kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

CCN3/CCN2 regulation and the fibrosis of diabetic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Connective tissue growth factor and renal diseases: some answers, more questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Regulation of PDGF and its receptors in fibrotic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

A new look at platelet-derived growth factor in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Patients with IgA nephropathy exhibit high systemic PDGF-DD levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

PDGF-C Expression in the Developing and Normal Adult Human Kidney and in Glomerular Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Effects of PDGF A-chain antisense oligodeoxynucleotides on growth of cardiovascular organs in stroke-prone spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

PDGF-C mediates glomerular capillary repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Angiogenesis in the kidney: a new therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Disturbance of lymph circulation develops renal fibrosis in rats with or without contralateral nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Connective Tissue Growth Factor Expressed in Tubular Epithelium Plays a Pivotal Role in Renal Fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Lymphatic Microvessels in the Rat Remnant Kidney Model of Renal Fibrosis: Aminopeptidase P and Podoplanin Are Discriminatory Markers for Endothelial Cells of Blood and Lymphatic Vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

Bone Morphogenic Protein-7 Induces Mesenchymal to Epithelial Transition in Adult Renal Fibroblasts and Facilitates Regeneration of Injured Kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

PDGF-AB release during and after haemodialysis procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05487.X

10.1111/J.1440-1681.2011.05487.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference